medigraphic.com
ISSN 2221-2434 (Electronic)

2019, Number 3

<< Back Next >>

Finlay 2019; 9 (3)

Non-diffuse large B-cell lymphoma. Case presentation

Serra VMÁ, Borrego MY, Viera GM

Language: Spanish
References: 12
Page: 226-231
PDF size: 155.31 Kb.


ABSTRACT

Diffuse B-cell lymphoma is the most common type of non-Hodgkin lymphoma in adults characterized by its aggressiveness and wide location. The first sign of its presence is a rapidly growing mass of lymph nodes. The case of a 64-year-old patient is presented, with a pathological history of arterial hypertension, ex-smoker, who was admitted because for 3 months she had increased volume of the left lateral region of the neck. Clinical studies, imaging, aspiration cytology, medullogram and spinal biopsy and lymph node biopsy allowed diagnosis and staging to begin treatment with cyclophosphamide, doxorubicin, vincristine and prednisone plus the monoclonal antibody rituximab according to the protocol for these tumors. Two months after treatment, the reduction of ganglionic masses had been achieved. The case is presented because it is of interest to specialists and training personnel.


REFERENCES

  1. Ministerio de Salud Pública. Anuario Estadístico de Salud 2018 [Internet]. La Habana: Dirección Nacional de Estadísticas; 2019 [citado 5 Sep 2019]. Disponible en: http://www.sld.cu/sitios/dne/

  2. López A, Bosch F. Linfoma difuso de células B grandes. En: Farreras R. Medicina Interna. 18va. ed. España: Elsevier; 2016: p. 1663-7

  3. Campo E. Non-hodgkin lymphomas: mature b-cell neoplasms. En: Campo E. Clinical Hematology. 4ta. ed. España: Elsevier; 2015: p. 327-40

  4. Philip J, Bierman Y, Armitage JO. Linfoma difuso de linfocitos b grandes. En: Philip J, Bierman Y, Armitage JO. Goldman-Cecil. Tratado de Medicina Interna. 21a. ed. Barcelona: Elsevier; 2017: p. 1264-66

  5. Moré JC, Hernández D, Santo Y. Linfoma difuso de células B grandes. Mediciego [revista en Internet]. 2017 [citado 29 May 2018];23(2):[aprox. 5p]. Disponible en: http://wwww.revmediciego.sld.cu

  6. Beltrán BE, De La Cruz JA. Características clínicas y sobrevida de los pacientes con linfoma de células grandes B difuso tratados con R-CHOP [Internet]. Lima: Universidad Ricardo Palma; 2017 [citado 23 Oct 2018]. Disponible en: http://repositorio.urp.edu.pe/bitstream/handle/ur p/1057/Brady_Beltrán.pdf?sequence=1&isAllowe d=y

  7. San Miguel JF, Sánchez FM. Linfomas no Hodgkin. En: San Miguel JF, Sánchez FM. Hematología. Manual Básico razonado. 3ra. ed. España: Elsevier; 2014: p. 141-52

  8. Grimm K, Omalley DP. Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues. Andiagpathol. 2018;38(1):6-10

  9. Castillo JJ. Linfoma de células grandes b difuso, epstein-barr virus positivo. Rev Fac Med Hum [revista en Internet]. 2017 [citado 23 Dic 2018];17(3):[aprox. 10p]. Disponible en: https://www.revistas.urp.edu.pe/index.php/rfmh/ article/download/1196/1090

  10. Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-Hodgkin lymphoma. Lancet. 2017;390(10091):298-310

  11. Al Hamadani M, Habermann TM, Cerhan JR, Macon WR, Maurer MJ, Go RS. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: a longitudinal analysis of the National Cancer Data Base from 1998 to 2011. Am J Hematol. 2015;90(9):790-5

  12. Guevara NM, Jaramillo PE, Rendón, J, Gaviria LM. Caracterización de factores pronósticos en pacientes con linfoma B difuso de células grandes. Acta Médica Colombiana [revista en Internet]. 2014 [citado 23 Sep 2018];39(2):[aprox. 10p]. Disponible en: https://www.redalyc.org/articulo.oa?id=1631314 92009




2020     |     www.medigraphic.com